Weinheim, Germany

Hans-Martin Kloetzer

This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Roche Diabetes Care, Inc., Roche Diagnostics Operations, Inc.. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Martin Kloetzer. Retrieved from https://idiyas.com/inventor/hans-martin-kloetzer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Mannheim, DE (2014)
  • Weinheim, DE (2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Hans-Martin Kloetzer

Introduction

Hans-Martin Kloetzer is a notable inventor based in Weinheim, Germany. He has made significant contributions to the field of medical technology, particularly in the area of sensor technology for measuring analyte concentrations in vivo. With a total of 2 patents, Kloetzer's work has the potential to impact the diagnosis and management of metabolic diseases.

Latest Patents

Kloetzer's latest patents include a method for detecting a malfunction of a sensor for measuring an analyte concentration in vivo. This invention relates to a method that produces a series of measurement signals through the sensor. A value of a noise parameter is continually determined from these signals, indicating how severely the measurement is impaired by interference signals. The invention utilizes continually determined values of the noise parameter to assess how quickly it changes, allowing for the detection of malfunctions based on the rate of change.

Another significant patent is an analytical method and investigation system for evaluating metabolism diseases. This system employs a sensor to measure the concentration of a medically significant analyte in human or animal body fluids. The measurement data is correlated with the analyte concentration over a time period of at least eight hours. The analytical facility analyzes time intervals within this period to determine a stability parameter that characterizes the dynamics of analyte concentration changes. This analysis further helps in identifying disease-related particularities of metabolism.

Career Highlights

Throughout his career, Kloetzer has worked with prominent companies such as Roche Diabetes Care, Inc. and Roche Diagnostics Operations, Inc. His experience in these organizations has contributed to his expertise in medical technology and innovation.

Collaborations

Kloetzer has collaborated with notable professionals in his field, including Arnulf Staib and Guenther Schmelzeisen-Redeker. These collaborations have likely enriched his work and contributed to the development of his innovative patents.

Conclusion

Hans-Martin Kloetzer's contributions to sensor technology and medical diagnostics exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving the detection and management of metabolic diseases, showcasing the potential of technology to enhance patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…